21 June 2021
07:00 am PT | 10:00 pm ET | 15:00 BST | 16:00 CEST
Immuno-oncology (IO) is a rapidly developing therapeutic approach, which harnesses the precision of the immune system, to allow for a targeted approach in the killing of cancer cells, whilst sparing healthy cells.
A rapid increase in recent clinical approvals has been seen, for both cell-based and antibody approaches. However, many obstacles remain in the development and understanding of these therapeutics.
Through the introduction of live-cell analysis, researchers can increase their biological insights, in supporting the development of future therapeutics.
Direction on how live-cell analysis can be incorporated into development workflows
How live-cell analysis can provide efficient, biological insight for bio-therapeutics
Case study data to support the use of Incucyte® Live-Cell Analysis Systems
Live questions and answers
Nicola Bevan, Manager of Cell Imaging Applications, Sartorius
Nicola Bevan is a manager of a Cell Imaging Applications group, working within the European based Bio Analytics research team. She is involved in the research and development of novel kinetic applications for Incucyte® Live-Cell Analysis Systems, expanding their system capabilities.
She is a highly experienced cellular pharmacologist with more than 25 years’ experience. Nicola has worked within the Pharmaceutical and Biotechnology industries, where she has gained broad experiences from a large pharmaceutical (GSK) industrial screening department, and has supported of early drug discovery programs.